विवरण

Anti-inflammatory drugs block certain substances in the body that cause inflammation ((redness, swelling, and pain)). They are used to treat many different conditions. The global anti-inflammatory drugs market is set to increase by US$ 43.8 अरब से 2022 को 2028, एक चक्रवृद्धि वार्षिक वृद्धि दर का प्रतिनिधित्व करना (सीएजीआर) का 6.1% पूर्वानुमान अवधि के दौरान.

रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2018-2021 और पूर्वानुमान करें 2028 covering key market aspects like sales value for anti-inflammatory drugs. The global anti-inflammatory drugs market is segmented on the basis of drug class, indication, route of administration, और क्षेत्र. On the basis of drug class, the global anti-inflammatory drugs market has been segmented into biologics & biosimilars, non-steroidal anti-inflammatory drugs (NSAIDs), steroids, अन्य. The biologics & biosimilars segment held the largest revenue share in 2021. By indication, the global anti-inflammatory drugs market has been segmented into autoimmune diseases, respiratory diseases, अन्य. इनमे से, the autoimmune diseases segment was accounted for the highest revenue generator in 2021. Based on route of administration, the global anti-inflammatory drugs market is categorized into parenteral, oral, topical, inhalational. भूगोल की दृष्टि से, the global anti-inflammatory drugs market has been segmented into Asia Pacific, यूरोप, उत्तरी अमेरिका, शेष विश्व (पंक्ति). According to the research, North America had the largest share in the global anti-inflammatory drugs market.

The global anti-inflammatory drugs market is highly competitive. Some of the leading companies operating in the market are AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Biogen Inc., Bristol-Myers Squibb Company, Cipla Limited, डॉ. Reddys Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Glenmark Pharmaceuticals Limited, GSK plc, Johnson & Johnson, Merck & सह. इंक, Novartis International AG, Pfizer Inc., Sanofi S.A.

यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the anti-inflammatory drugs market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.

रिपोर्ट का दायरा

Drug class: biologics & biosimilars, non-steroidal anti-inflammatory drugs (NSAIDs), steroids, अन्य
Indication: autoimmune diseases, respiratory diseases, अन्य
Route of administration: parenteral, oral, topical, inhalational
क्षेत्र: एशिया प्रशांत, यूरोप, उत्तरी अमेरिका, शेष विश्व (पंक्ति)
वर्षों पर विचार किया गया: यह रिपोर्ट उस अवधि को कवर करती है 2018 को 2028

हितधारकों के लिए मुख्य लाभ

– Get a comprehensive picture of the global anti-inflammatory drugs market
– विकास क्षेत्रों और निवेश के रुझानों को इंगित करें

विषयसूची

भाग 1. परिचय
– अध्ययन का दायरा
– शिक्षा काल
– भौगोलिक गुंजाइश
– अनुसंधान क्रियाविधि
भाग 2. Anti-inflammatory drugs market overview
भाग 3. Market breakdown by drug class
– Biologics & biosimilars
– Non-steroidal anti-inflammatory drugs (NSAIDs)
– Steroids
– अन्य
भाग 4. Market breakdown by indication
– Autoimmune diseases
– Respiratory diseases
– अन्य
भाग 5. Market breakdown by route of administration
– Parenteral
– Oral
– Topical
– Inhalational
भाग 6. क्षेत्र के अनुसार बाज़ार का विभाजन
– एशिया प्रशांत
– यूरोप
– उत्तरी अमेरिका
– शेष विश्व (पंक्ति)
भाग 7. प्रमुख कंपनियाँ
– AbbVie Inc.
– Amgen Inc.
– AstraZeneca plc
– Bayer AG
– Biogen Inc.
– Bristol-Myers Squibb Company
– Cipla Limited
– डॉ. Reddys Laboratories Ltd.
– Eli Lilly and Company
– F. Hoffmann-La Roche AG
– Glenmark Pharmaceuticals Limited
– GSK plc
– Johnson & Johnson
– Merck & Co., इंक.
– Novartis International AG
– Pfizer Inc.
– Sanofi S.A.
स्ट्रेटेजीहेलिक्स के बारे में
अस्वीकरण